Results 191 to 200 of about 630,791 (206)

Immunogenicity and adverse effects of pneumococcal vaccines co-administered with influenza or SARS-CoV-2 vaccines in adults: A systematic review and Meta-analysis

Hassan Rahimi, Almas Ayad Jasim, Omid Rezahosseini, Zitta Barrella Harboe   +3 more
openalex   +1 more source

A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand

, 2018
Lijoy Varghese, Louise Talbot, Andrea Govender, Xuhao Zhang, Bruce A. Mungall   +4 more
openalex   +1 more source

Immunogenicity and Safety of the Higher-Valent Pneumococcal Conjugate Vaccine vs the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Thundon Ngamprasertchai, Narisa Ruenroegnboon, Rattagan Kajeekul   +2 more
openalex   +1 more source

Physicians' awareness and practice toward influenza and pneumococcal vaccines for high-risk patients.

J Family Med Prim Care, 2019
Amin HS, Arafa MA, Al-Omair BM.
europepmc   +1 more source

Pneumococcal vaccination offer and schedules in adults in EU countries: An update. [PDF]

Hum Vaccin Immunother
Chiavarini M, Boccalini S, Bechini A, Barash A, Castellana E, Senape A, Bonanni P.   +6 more
europepmc   +1 more source

Coverage of the influenza and pneumococcal vaccinations among immigrant and non-immigrant older adults in Canada: a cross-sectional analysis of data from the Canadian Longitudinal Study on Aging (CLSA). [PDF]

BMC Public Health
Kim JY, Sulis G, Russell A, Yang S, Papenburg J, Banerjee A, Li P.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Development of pneumococcal vaccines over the last 10 years

Expert Opinion on Biological Therapy, 2018
N. Principi, S. Esposito
semanticscholar   +1 more source